SAN.PA | Sanofi78.49 -0.82 (-1.06%)  Latest Earnings Call / Transcript of Sanofi (SAN.PA)We haven't found the most latest Earnings Call recordings yet. Stay tuned and we'll add it here as soon as we found it.
Earnings History Date | EPS / Forecast | Revenue / Forecast | | February 5, 2021 | 1.22 / 1.14 | 9.38B / 9.72B | | October 29, 2020 | 1.83 / 1.76 | 9.88B / 9.77B | Beat!
| July 29, 2020 | 1.28 / 1.2 | 8.44B / 8.55B | | April 24, 2020 | 1.63 / 1.45 | 9.32B / 9.27B | Beat!
| February 6, 2020 | 1.34 / 1.27 | 9.61B / 9.89B | | October 31, 2019 | 1.92 / 1.71 | 9.5B / 9.44B | Beat!
| July 29, 2019 | 1.31 / 1.26 | 8.63B / 8.58B | Beat!
| April 26, 2019 | 1.42 / 1.32 | 8.39B / 8.44B | | February 7, 2019 | 1.1 / 1.09 | 9B / 9.01B | | October 31, 2018 | 1.84 / 1.71 | 9.39B / 9.29B | Beat!
| July 31, 2018 | 1.25 / 1.2 | 8.18B / 8.3B | | April 27, 2018 | 1.28 / 1.11 | 7.9B / 8B | | February 7, 2018 | 1.06 / 1.16 | 18.37B / 8,834M | | November 2, 2017 | 1.71 / 1.71 | 9.39B / 9,411M | | July 31, 2017 | 1.35 / 1.30 | 17.83B / 8,713M | | News about Sanofi earnings - Sanofi Named One of America's Best Employers by Forbes
finance.yahoo.com Apr 17, 2019 7:04 pm - Sanofi Named One of America's Best Employers by Forbes - PRNewswire
prnewswire.com Apr 17, 2019 7:04 pm - Sanofi provides insulins access at $99 - Sanofi (NASDAQ:SNY) - Seeking Alpha
seekingalpha.com Apr 12, 2019 8:04 pm - Health Canada issues Notice of Compliance with Conditions (NOC/c) for LibtayoTM (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC)
finance.yahoo.com Apr 11, 2019 7:04 pm - Sanofi: Disclosure of trading in own shares
finance.yahoo.com Apr 10, 2019 8:04 pm - Sanofi: Disclosure of trading in own shares - Nasdaq
nasdaq.com Apr 10, 2019 8:04 pm - Global Splenomegaly Therapeutics Market 2019-2023 with Market Positioning of Vendors - GSK, Incyte, Merck & Co, Novartis & Sanofi
globenewswire.com Apr 7, 2019 8:04 am - Brainstorm Health: E. Coli Outbreak, Memorial Sloan Kettering, Treating Cancer With Light - Fortune
fortune.com Apr 5, 2019 7:04 pm - FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes - Reuters
reuters.com Mar 22, 2019 7:03 pm - House Calls by Smartphone? LatAm Tech Unicorn Teams With Sanofi - Bloomberg
bloomberg.com Mar 21, 2019 7:03 pm - Diabetes Injection Pens Market to Witness Huge Growth by 2025 | Leading Key Players- AstraZeneca, Biocon, Sanofi, Becton
marketwatch.com Mar 20, 2019 8:03 am - Exclusive: Sanofi says working at hiring a new CEO
reuters.com Mar 18, 2019 7:03 pm - Sanofi working on CEO succession plan
seekingalpha.com Mar 18, 2019 7:03 pm - EC OKs CV benefit claim for Regeneron and Sanofi's Praluent
seekingalpha.com Mar 15, 2019 7:03 pm - France : Sanofi successfully prices EUR 2 billion of bond issues
marketwatch.com Mar 14, 2019 7:03 pm - Regeneron and Sanofi to Present New Praluent® (alirocumab) Data at ACC.19
prnewswire.com Mar 13, 2019 9:03 am - Sanofi's Dupixent Gets FDA Priority Status for Nasal Polyps
zacks.com Mar 11, 2019 9:03 am - Manila to charge Sanofi officials over dengue vaccination deaths
msn.com Mar 3, 2019 8:03 am - Sanofi sets a fixed price of insulin at $99 per month for some patients
finance.yahoo.com Apr 10, 2019 8:04 pm - Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance
finance.yahoo.com Apr 8, 2019 8:04 am - Sanofi: Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance
finance.yahoo.com Apr 8, 2019 8:04 am - CDC: 44 States Still Reporting High Flu Activity
finance.yahoo.com Mar 29, 2019 7:03 pm - What's Next for Lexicon Pharmaceuticals?
finance.yahoo.com Mar 25, 2019 7:03 pm - This Pharma Giant Slipped After FDA Rejected Its Diabetes Treatment
finance.yahoo.com Mar 22, 2019 7:03 pm - Exclusive: Sanofi says working on CEO succession plan
finance.yahoo.com Mar 18, 2019 7:03 pm - Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease
finance.yahoo.com Mar 15, 2019 7:03 pm - Sanofi successfully prices EUR 2 billion of bond issues
finance.yahoo.com Mar 13, 2019 6:03 pm - Regeneron/Sanofi wins U.S. approval for expanded use of skin drug
finance.yahoo.com Mar 11, 2019 7:03 pm - FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents
finance.yahoo.com Mar 11, 2019 7:03 pm - How Much is Sanofi's (EPA:SAN) CEO Getting Paid?
finance.yahoo.com Mar 6, 2019 8:03 am
| | Share it with fellow traders: or join discussions in FB below ( FB comments ) If you are looking for News & events, Press Release, they are available on their Investors Relationssite. If you want to help pay for server cost or for improving this tool. You can send it via Paypal. More features coming soon :) Buy on AmazonGraham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949. The best book on investing ever written. -- Warren Buffet |